Human Molecular Genetics, 2000, Vol. 9, No. 7 1119-1129
© 2000 Oxford University Press
Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: correlation of disease severity with mutation type and location
Institute of Medical Genetics, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN, UK, 1Department of Psychological Medicine, University of Glasgow, Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, G12 OXH, UK, 2TVW Telethon Institute for Child Health Research, West Perth, WA 6872, Australia, 3Department of Human Genetics, University of Newcastle upon Tyne, 19/20 Claremont Place, Newcastle upon Tyne, NE2 4AA, UK and 4Department of Biological Sciences, University of Warwick, UK
Mutations in the methyl-CpG-binding protein gene MECP2 at Xq28 cause Rett syndrome (RTT), an X-linked dominant neurodevelopmental disorder characterized by a period of stagnation followed by regression in the development of young girls. Mutations were sought in MECP2 in 48 females with classical sporadic RTT, seven families with possible familial RTT and five sporadic females with features suggestive, but not diagnostic of RTT. Long distance PCR coupled with long-read direct sequencing was employed to sequence the entire MECP2 gene coding region in all cases. Mutations were identified in 44/55 (80%) unrelated classical sporadic and familial RTT patients, but only 1/5 (20%) sporadic cases with suggestive but non-diagnostic features of RTT. Twenty-one different mutations were identified (12 missense, four nonsense and five frame-shift mutations); 14 of these were novel. All missense mutations were located either in the methyl-CpG-binding domain or in the transcription repression domain. Nine recurrent mutations were characterized in a total of 33 unrelated cases (73% of all cases with MECP2 mutations). Significantly milder disease was noted in patients carrying missense mutations as compared with those with truncating mutations (P = 0.0023), and milder disease was associated with late as compared with early truncating mutations (P = 0.0190).
+ These authors contributed equally to this work
§ To whom correspondence should be addressed. Tel: +44 29 20744035; Fax: +44 29 20747603; Email: clarkeaj@cardiff.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Rusconi, L. Salvatoni, L. Giudici, I. Bertani, C. Kilstrup-Nielsen, V. Broccoli, and N. Landsberger CDKL5 Expression Is Modulated during Neuronal Development and Its Subcellular Distribution Is Tightly Regulated by the C-terminal Tail J. Biol. Chem., October 31, 2008; 283(44): 30101 - 30111. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nectoux, N. Bahi-Buisson, I. Guellec, J. Coste, N. D. Roux, H. Rosas, M. Tardieu, J. Chelly, and T. Bienvenu The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome Neurology, May 27, 2008; 70(22_Part_2): 2145 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and B. A. Minassian Will my Rett syndrome patient walk, talk, and use her hands? Neurology, April 15, 2008; 70(16): 1302 - 1303. [Full Text] [PDF] |
||||
![]() |
J. L. Neul, P. Fang, J. Barrish, J. Lane, E. B. Caeg, E. O. Smith, H. Zoghbi, A. Percy, and D. G. Glaze Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome Neurology, April 15, 2008; 70(16): 1313 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bebbington, A. Anderson, D. Ravine, S. Fyfe, M. Pineda, N. de Klerk, B. Ben-Zeev, N. Yatawara, A. Percy, W. E. Kaufmann, et al. Investigating genotype-phenotype relationships in Rett syndrome using an international data set Neurology, March 11, 2008; 70(11): 868 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Huppke, E M Maier, A Warnke, C Brendel, F Laccone, and J Gartner Very mild cases of Rett syndrome with skewed X inactivation J. Med. Genet., October 1, 2006; 43(10): 814 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Laurvick, M. E. Msall, S. Silburn, C. Bower, N. d. Klerk, and H. Leonard Physical and Mental Health of Mothers Caring for a Child With Rett Syndrome Pediatrics, October 1, 2006; 118(4): e1152 - e1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
H L Archer, S D Whatley, J C Evans, D Ravine, P Huppke, A Kerr, D Bunyan, B Kerr, E Sweeney, S J Davies, et al. Gross rearrangements of the MECP2 gene are found in both classical and atypical Rett syndrome patients J. Med. Genet., May 1, 2006; 43(5): 451 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, September 1, 2005; 20(9): 736 - 740. [Abstract] [PDF] |
||||
![]() |
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, September 1, 2005; 20(9): 768 - 778. [Abstract] [PDF] |
||||
![]() |
H. Y. Zoghbi MeCP2 Dysfunction in Humans and Mice J Child Neurol, August 1, 2005; 20(8): 736 - 740. [Abstract] [PDF] |
||||
![]() |
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen Does Genotype Predict Phenotype in Rett Syndrome? J Child Neurol, August 1, 2005; 20(8): 768 - 778. [Abstract] [PDF] |
||||
![]() |
H. Moore, H. Leonard, N. de Klerk, I. Robertson, S. Fyfe, J. Christodoulou, L. Weaving, M. Davis, S. Mulroy, and L. Colvin Health Service Use in Rett Syndrome J Child Neurol, January 1, 2005; 20(1): 42 - 50. [Abstract] [PDF] |
||||
![]() |
Jong Hee Chae, Hee Hwang, Yong Seung Hwang, Hee Jung Cheong, and Ki Joong Kim Influence of MECP2 Gene Mutation and X-Chromosome Inactivation on the Rett Syndrome Phenotype J Child Neurol, July 1, 2004; 19(7): 503 - 508. [Abstract] [PDF] |
||||
![]() |
J. L. Neul and H. Y. Zoghbi Rett Syndrome: A Prototypical Neurodevelopmental Disorder Neuroscientist, April 1, 2004; 10(2): 118 - 128. [Abstract] [PDF] |
||||
![]() |
R. C. Samaco, R. P. Nagarajan, D. Braunschweig, and J. M. LaSalle Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders Hum. Mol. Genet., March 15, 2004; 13(6): 629 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Inlow and L. L. Restifo Molecular and Comparative Genetics of Mental Retardation Genetics, February 1, 2004; 166(2): 835 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Colvin, H Leonard, N de Klerk, M Davis, L Weaving, S Williamson, and J Christodoulou Refining the phenotype of common mutations in Rett syndrome J. Med. Genet., January 1, 2004; 41(1): 25 - 30. [Full Text] [PDF] |
||||
![]() |
S. Kriaucionis and A. Bird DNA methylation and Rett syndrome Hum. Mol. Genet., October 15, 2003; 12(90002): R221 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Naidu, G. Bibat, L. Kratz, R. I. Kelley, J. Pevsner, E. Hoffman, C. Cuffari, C. Rohde, M. E. Blue, and M. V. Johnston Clinical Variability in Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 662 - 668. [Abstract] [PDF] |
||||
![]() |
J. Christodoulou and L. S. Weaving MECP2 and Beyond: Phenotype--Genotype Correlations in Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 669 - 674. [Abstract] [PDF] |
||||
![]() |
S. Fyfe, A. Cream, N. de Klerk, J. Christodoulou, and H. Leonard InterRett and RettBASE: International Rett Syndrome Association Databases for Rett Syndrome J Child Neurol, October 1, 2003; 18(10): 709 - 713. [Abstract] [PDF] |
||||
![]() |
S Kudo, Y Nomura, M Segawa, N Fujita, M Nakao, C Schanen, and M Tamura Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain J. Med. Genet., July 1, 2003; 40(7): 487 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Gill, J P Cheadle, J Maynard, N Fleming, S Whatley, T Cranston, E M Thompson, H Leonard, M Davis, J Christodoulou, et al. Mutation analysis in the MECP2 gene and genetic counselling for Rett syndrome J. Med. Genet., May 1, 2003; 40(5): 380 - 384. [Full Text] [PDF] |
||||
![]() |
H Leonard, L Colvin, J Christodoulou, T Schiavello, S Williamson, M Davis, D Ravine, S Fyfe, N de Klerk, T Matsuishi, et al. Patients with the R133C mutation: is their phenotype different from patients with Rett syndrome with other mutations? J. Med. Genet., May 1, 2003; 40(5): e52 - 52. [Full Text] [PDF] |
||||
![]() |
M. F. Fraga, E. Ballestar, G. Montoya, P. Taysavang, P. A. Wade, and M. Esteller The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties Nucleic Acids Res., March 15, 2003; 31(6): 1765 - 1774. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Turner, F MacDonald, S Warburton, F Latif, and T Webb Developmental delay and the methyl binding genes J. Med. Genet., February 1, 2003; 40(2): e13 - 13. [Full Text] [PDF] |
||||
![]() |
G. M. Liebhaber, E. Riemann, and F. A. Matthias Baumeister Ketogenic Diet in Rett Syndrome J Child Neurol, January 1, 2003; 18(1): 74 - 75. [Abstract] [PDF] |
||||
![]() |
K Ravn, J B Nielsen, P Uldall, F J Hansen, and M Schwartz No correlation between phenotype and genotype in boys with a truncating MECP2 mutation J. Med. Genet., January 1, 2003; 40(1): e5 - 5. [Full Text] [PDF] |
||||
![]() |
L Colvin, S Fyfe, S Leonard, T Schiavello, C Ellaway, N de Klerk, J Christodoulou, M Msall, and H Leonard Describing the phenotype in Rett syndrome using a population database Arch. Dis. Child., January 1, 2003; 88(1): 38 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Laccone, B Zoll, P Huppke, F Hanefeld, W Pepinski, and R Trappe MECP2 gene nucleotide changes and their pathogenicity in males: proceed with caution J. Med. Genet., August 1, 2002; 39(8): 586 - 588. [Full Text] [PDF] |
||||
![]() |
B. Ben Zeev, Y. Yaron, N. C. Schanen, H. Wolf, N. Brandt, N. Ginot, R. Shomrat, and A. Orr-Urtreger Rett Syndrome: Clinical Manifestations in Males With MECP2 Mutations J Child Neurol, January 1, 2002; 17(1): 20 - 24. [Abstract] [PDF] |
||||
![]() |
Jong Hee Chae, Yong Seung Hwang, and Ki Joong Kim Mutation Analysis of MECP2 and Clinical Characterization in Korean Patients With Rett Syndrome J Child Neurol, January 1, 2002; 17(1): 33 - 36. [Abstract] [PDF] |
||||
![]() |
V. Bourdon, C. Philippe, T. Bienvenu, B. Koenig, M. Tardieu, J. Chelly, and P. Jonveaux Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: diagnostic implications J. Med. Genet., December 1, 2001; 38(12): 867 - 871. [Full Text] [PDF] |
||||
![]() |
J. M. LaSalle, J. Goldstine, D. Balmer, and C. M. Greco Quantitative localization of heterogeneous methyl-CpG-binding protein 2 (MeCP2) expression phenotypes in normal and Rett syndrome brain by laser scanning cytometry Hum. Mol. Genet., August 1, 2001; 10(17): 1729 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hoffbuhr, J. M. Devaney, B. LaFleur, N. Sirianni, C. Scacheri, J. Giron, J. Schuette, J. Innis, M. Marino, M. Philippart, et al. MeCP2 mutations in children with and without the phenotype of Rett syndrome Neurology, June 12, 2001; 56(11): 1486 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Leonard, J. Silberstein, R. Falk, I. Houwink-Manville, C. Ellaway, L. S. Raffaele, I. Witt Engerstrom, and C. Schanen Occurrence of Rett Syndrome in Boys J Child Neurol, May 1, 2001; 16(5): 333 - 338. [Abstract] [PDF] |
||||
![]() |
P. Couvert, T. Bienvenu, C. Aquaviva, K. Poirier, C. Moraine, C. Gendrot, A. Verloes, C. Andres, A. C. Le Fevre, I. Souville, et al. MECP2 is highly mutated in X-linked mental retardation Hum. Mol. Genet., April 1, 2001; 10(9): 941 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Webb and F. Latif Rett syndrome and the MECP2 gene J. Med. Genet., April 1, 2001; 38(4): 217 - 223. [Full Text] |
||||
![]() |
M. Auranen, R. Vanhala, M. Vosman, M. Levander, T. Varilo, M. Hietala, R. Riikonen, L. Peltonen, and I. Jarvela MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features Neurology, March 13, 2001; 56(5): 611 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Yusufzai and A. P. Wolffe Functional consequences of Rett syndrome mutations on human MeCP2 Nucleic Acids Res., November 1, 2000; 28(21): 4172 - 4179. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Villard, A. Kpebe, C. Cardoso, J. Chelly, M. Tardieu, and M. Fontes Two affected boys in a Rett syndrome family: Clinical and molecular findings Neurology, October 24, 2000; 55(8): 1188 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dragich, I. Houwink-Manville, and C. Schanen Rett syndrome: a surprising result of mutation in MECP2 Hum. Mol. Genet., October 1, 2000; 9(16): 2365 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Huppke, F. Laccone, N. Kramer, W. Engel, and F. Hanefeld Rett syndrome: analysis of MECP2 and clinical characterization of 31 patients Hum. Mol. Genet., May 22, 2000; 9(9): 1369 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Free, R. I. D. Wakefield, B. O. Smith, D. T. F. Dryden, P. N. Barlow, and A. P. Bird DNA Recognition by the Methyl-CpG Binding Domain of MeCP2 J. Biol. Chem., January 26, 2001; 276(5): 3353 - 3360. [Abstract] [Full Text] [PDF] |
||||









